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Abstract 23 
To bridge the gap between preclinical cellular models of disease and in vivo imaging of human 24 
cognitive network dynamics, there is a pressing need for informative biophysical models. Here we 25 
assess dynamic causal models (DCM) of cortical network responses, as generative models of 26 
magnetoencephalographic observations during an auditory oddball roving paradigm in healthy 27 
adults. This paradigm induces robust perturbations that permeate frontotemporal networks, 28 
including an evoked ‘mismatch negativity’ response and transiently induced oscillations. Here, we 29 
probe GABAergic influences of the networks using double-blind placebo-controlled randomised-30 
crossover administration of the GABA re-uptake inhibitor, tiagabine (oral, 10mg) in healthy older 31 
adults. We demonstrate the facility of conductance-based neural mass mean-field models, 32 
incorporating local synaptic connectivity, to investigate laminar-specific and GABAergic mechanisms 33 
of the auditory response. The neuronal model accurately recapitulated the observed 34 
magnetoencephalographic data. Using parametric empirical Bayes for optimal model inversion 35 
across both drug sessions, we identify the effect of tiagabine on GABAergic modulation of deep 36 
pyramidal and interneuronal cell populations.  We found a transition of the main GABAergic drug 37 
effects from auditory cortex in standard trials to prefrontal cortex in deviant trials. The successful 38 
integration of pharmaco- magnetoencephalography with dynamic causal models of frontotemporal 39 
networks provides a potential platform on which to evaluate the effects of disease and 40 
pharmacological interventions.   41 
Significance Statement 42 
Understanding human brain function and developing new treatments require good models of brain 43 
function. We tested a detailed generative model of cortical microcircuits that accurately reproduced 44 
human magnetoencephalography, to quantify network dynamics and connectivity in frontotemporal 45 
cortex. This approach identified the effect of a test drug (GABA-reuptake inhibitor, tiagabine) on 46 
neuronal function (GABA-ergic dynamics), opening the way for psychopharmacological studies in 47 
health and disease with the mechanistic precision afforded by generative models of the brain.  48 
  49 
Introduction 50 
Biophysically informed models of cognition and cognitive disorders facilitate the effective translation 51 
of the mechanisms and treatments of disease. Recent progress towards detailed generative models 52 
that replicate neurophysiological correlates of cognition based on cellular and network dynamics, 53 
such as ‘Dynamic Causal Models’ (DCM), make predictions that approximate observations by 54 
functional magnetic resonance imaging or electro- and magneto-encephalography (MEG) (Moran et 55 
al., 2013). To be most useful, these models should incorporate laminar, cellular and synaptic 56 
functions (Bastos et al., 2012), and adhere to basic principles of cortical connectivity (Shipp, 2016), 57 
while also being sufficiently tractable and accurate to study cognition.  58 
The DCM framework developed to meet these criteria, with applications in health and neurological 59 
disorders (Kiebel et al., 2008; Stephan et al., 2008; Boly et al., 2011; Marreiros et al., 2015). DCMs 60 
draw on empirical priors for synaptic time constants and conductances, together with a mean-field 61 
forward model. They are optimised to match the observed neurophysiological data. DCMs are 62 
supported by extensive data for face-validity (Stephan et al., 2008, 2015) and construct-validity (Razi 63 
et al., 2015), but they must also achieve predictive validity (Moran et al., 2014; Gilbert and Moran, 64 
2016; Shaw et al., 2018).  65 
We tested the ability of DCMs to identify the effect of a pharmacological intervention. The DCMs 66 
were designed to model human frontotemporal cortical networks during an auditory oddball 67 
paradigm, with characteristic MEG responses to standard and deviant tones (<300ms). The 68 
differential response to these tones (the Mismatch Negativity, MMN) is abnormal in many 69 
neurological diseases (Boly et al., 2011; Naatanen et al., 2011; Hughes et al., 2013), reflecting a 70 
change in prediction errors in hierarchical frontotemporal networks (Garrido et al., 2009b; Phillips et 71 
al., 2015).  72 
To examine laminar- and synaptic-dynamics in response to auditory stimuli we developed a new 73 
DCM with six cell populations, called “ext-DCM”. In six connected regions (locations from Phillips et 74 
al., 2015, 2016), we used a conductance-based mean-field cortical modelling scheme (cf. Moran et 75 
al., 2013; Marreiros et al., 2015). For auditory mismatch responses, both thalamocortical and 76 
cortico-cortical connections integrate feedforward sensory inputs and feedback expectations. The 77 
network architecture controls the flow and integration of information, via cell- and 78 
neurotransmitter-specific interactions. The ext-DCM introduces new cortico-thalamic burst-firing 79 
cells (‘tp’ in Figure 1a) that enable the model to generate beta activity from deep-layers (Roopun et 80 
al., 2008a, 2010; Bordas et al., 2015; Michalareas et al., 2016). The ext-DCM also separates the 81 
inhibitory interneuronal populations for superficial and deep pyramidal cells (e.g. Jiang et al., 2015). 82 
These extensions improve the DCMs’ functionality in terms of laminar dynamics. We tested the 83 
model’s ability to accurately generate evoked magnetoencephalographic responses (i.e. event 84 
related fields, ERF), under placebo and drug conditions.   85 
With the ext-DCM, we used the drug tiagabine to test how well the neurophysiological model could 86 
identify changes in the causes of observed neuronal dynamics. Tiagabine is a gamma-amino-butyric 87 
acid (GABA) re-uptake inhibitor. GABA is critical for the generation of physiological responses and 88 
rhythms in local and global processing (Whittington et al., 2000). This pharmacological specificity 89 
provides a more controlled acute test of DCMs than autoimmune (Symmonds et al., 2018) and 90 
genetic channelopathies (Gilbert et al., 2016). 91 
Using parametric empirical Bayes to optimise the model across participants and drug conditions we 92 
examined how modelled GABAergic dynamics are altered by tiagabine. Based on the hypothesis that 93 
prediction and prediction error depend on short-term GABAergic plasticity (Castro-Alamancos and 94 
Connors, 1996; Garrido et al., 2009a; Mongillo et al., 2018; Spriggs et al., 2018), we predicted that 95 
upper and lower hierarchical frontotemporal processing would be differentially affected by tiagabine 96 
during standard and deviant tones. 97 
In summary, the study’s principal aims were i) to introduce and assess the ext-DCM for generating 98 
the event-related fields observed by MEG, ii) to identify receptor-specific changes that govern these 99 
dynamics, comparing tiagabine and placebo treatment conditions, and iii) to assess whether these 100 
pharmacological effects are expressed dynamically across trial types and regions with laminar 101 
specificity. 102 
  103 
Materials and Methods 104 
Experimental Design:  105 
We undertook a randomised placebo-controlled double-blind crossover study of the effects of 106 
tiagabine in 20 healthy adults (aged 67.5±4.2, ten male). Participants had no neurological or 107 
psychiatric illness and were recruited from the MRC Cognition and Brain Sciences and Join Dementia 108 
Research volunteer panels. The study was approved by the Cambridge Research Ethics Committee 109 
and written informed consent was acquired, in keeping with the declaration of Helsinki.  110 
Neurophysiological responses were measured in an auditory roving oddball paradigm (Garrido et al., 111 
2008). Binaural sinusoidal tones were presented in phase via ear-pieces for 75 ms (with 7.5ms ramp 112 
up and down at start and end of the tone), at 500 ms intervals. The frequency of the tone increased 113 
or decreased in steps of 50 Hz (range 400 – 800 Hz). The change of frequency occurred after 114 
between 3 and 10 repetitions, with a truncated exponential distribution that approximated a stable 115 
expectancy of change over time. Auditory thresholds were assessed in quiet at 500, 1,000, and 1,500 116 
Hz. Tones were presented at 60dB above the average threshold for a standard population through 117 
the earpieces in the MEG. 118 
Each participant attended two MEG sessions with a minimum two weeks interval. They received 119 
either 10 mg oral tiagabine or a placebo, in randomised order. Bloods were taken 105 minutes later, 120 
immediately prior to MEG data acquisition, to coincide with peak plasma levels and CNS penetration 121 
(Nutt et al., 2015). 122 
Data Acquisition and pre-processing: 123 
Magnetoencephalography (MEG) used a 306-channel Vectorview acquisition system (Elekta 124 
Neuromag, Helsinki) in a light Elekta Neuromag magnetically-shielded room. This consists of a pair of 125 
gradiometers and a magnetometer at each of 102 locations, sampled at 1000 Hz. Vertical and 126 
horizontal EOGs tracked eye movements and 5 head-position indicator coils tracked head position. A 127 
MEG-Compatible 70 channel EEG cap (Easycap GmbH) using Ag/AgCl electrodes positioned 128 
according to the 10-20 system was used concurrently. A 3D digitizer (Fastrak Polhemus Inc., 129 
Colchester, VA) was used to record >100 scalp data points, nasion and bilateral pre-auricular 130 
fiducials. Subjects also underwent T1-weighted structural magnetic resonance imaging (MPRAGE 131 
sequence, TE = 2.9 msTR = 2000 ms, 1.1mm isotropic voxels) using a 3T Siemens PRISMA scanner.  132 
MEG data pre-processing included head position alignment and movement compensation using 6 133 
headcoils, placed around the head on the EEG cap, and employed the temporal extension of Signal 134 
Space Separation with MaxFilter v2.2 (Elekta Neuromag). The auto-detection of bad channels was 135 
combined with manual input of any channels logged as bad during data acquisition. The Statistical 136 
Parametric Mapping toolbox (SPM12) (The Wellcome Trust Centre for Neuroimaging, UCL, UK) was 137 
used for further pre-processing and analysis, in conjunction with modified and custom MATLAB 138 
scripts (MATLAB 2017a, Mathworks, Natick, MA). Data were Butterworth filtered between 1 and 180 139 
Hz, epoched from -100 ms to 400 ms relative to the auditory stimuli and artefact rejected using EOG, 140 
EEG and MEG channel thresholding. Spectral analyses were performed using a multi-taper method. 141 
The deviant trial was taken as the 1st trial of a train, regardless of the frequency and the 6th trial of a 142 
train was modelled as ‘standard’.  143 
Source reconstruction used a forward model estimated using the single shell cortical mesh from 144 
each individual’s T1-weighted MR structural scan. After co-registration using the fiducials and head 145 
points, local fields (LFs) for 6 sources of interest were source-reconstructed using SPM “COH” 146 
method, a combination of LORETA and minimum norm (Pascual-Marqui et al., 1994; Heers et al., 147 
2016). Sources of interest were (with MNI coordinates in standard space following inverse 148 
normalisation): left auditory cortex (LAud; -42, -22, 7), left superior temporal gyrus (LSTG; -61 -32 8), 149 
left inferior frontal gyrus (LIFG; -46 20 8), right auditory cortex (RAud; 46, -14, 8), right superior 150 
temporal gyrus (RSTG; 59 -25 8) and right inferior frontal gyrus (RIFG; 46 20 8). To create images of 151 
induced power, SPM-LORETA was used for source localization of a 5 mm3 regular grid at the MMN 152 
(150 – 250 ms) time window (100ms in width, regularization=0.05).  153 
Correlation coefficients for comparing the actual and predicted ERFs were calculated using the 154 
corrcoef function (Pearson correlation) in MATLAB 2017a for each individual, condition and node.  155 
Time-frequency analysis was performed in SPM12 using a multi-taper method with 100 ms windows 156 
overlapped by 5 ms and a bandwidth of 3. Frequency bands were split into alpha (8 – 13 Hz), beta 157 
(14 – 29 Hz), low gamma (30 – 48 Hz) and high gamma (52 – 80 Hz). 158 
Neuronal Modelling: an extended canonical microcircuit model 159 
We used conductance-based canonical mean field (CMM) models for evoked responses (Kiebel et al., 160 
2008) utilising canonical microcircuit models (SPM12, DCM10). This approach to 161 
neurophysiologically informed modelling using DCM goes beyond descriptive biomarkers by 162 
providing a mechanistic link to realistic microscopic processes. A common approach in DCM is to 163 
invert the neuronal and spatial forward model as a single generative model, to solve the source 164 
reconstruction and biophysical modelling problems jointly by fitting the DCM to sensor data. 165 
However, we modelled source specific responses to suppress conditional dependencies between the 166 
neuronal parameters and the parameters of a spatial forward model. This affords more efficient 167 
estimators of neuronal parameters, providing the source reconstruction is sufficiently precise given 168 
the spatial topography of the network of interest. This has the advantage of compatibility with 169 
multiple studies of this task (Muthukumaraswamy et al., 2015; Gilbert and Moran, 2016; Shaw et al., 170 
2017, 2018), including MEG and electrocorticography studies; the chosen network was based on the 171 
published bilateral A1, STG, IFG networks associated with the generation of the MMN response. 172 
Since this spatial element of the inverse problem was constrained, it is computationally more 173 
appropriate to source localise using SPM with prior expected sources. The subsequent DCM was 174 
then run on these virtual electrodes.  175 
Our DCM included a conductance-based neural-mass model at each of the six anatomical locations, 176 
as shown in Figure 1. We compared the default 4-cell conductance canonical-microcircuit model 177 
with the ext-DCM, comprising 6 cell modules: a superficial pyramidal module (sp), a deep cortico-178 
cortical pyramidal module (dp), a thalamic-projection pyramidal module (tp), a granular stellate 179 
module (ss) and separate supragranular and infragranular interneuron populations (si & di). 180 
Excitatory autapses existed for all excitatory cell modules and all modules were also governed by an 181 
inhibitory self-gain function that provided tonic inhibition to each module. The ext-DCM was 182 
compared to the standard 4-cell model that is standard in SPM and is described in detail in Kiebel et 183 
al. (2008). In summary, the 4-cell DCM lacks thalamocortical connectivity and has a unitary inhibitory 184 
population interacting with all pyramidal and stellate cell populations.  185 
The intrinsic connectivities are shown in Fig. 1a: note the excitatory conductances based on AMPA 186 
and NMDA and inhibitory GABA-A and GABA-B conductances. The model is an extension of the SPM 187 
conductance-based CMM model (SPM12, 2013): inclusion of separate supra- and infra-granular 188 
interneuron populations creates a more biophysically realistic model that allows a greater flexibility 189 
of independence of deep and superficial activity than in previous work (Bhatt et al., 2016; Shaw et 190 
al., 2018; Spriggs et al., 2018). Additionally, the new ‘tp’ population expressed a hyperpolarization-191 
activated cation current (H-current) and a non-inactivating potassium current (M-current) to provide 192 
surrogate intrinsic dynamics involved in the characteristic intrinsic bursting behaviour of these cells. 193 
These two currents were fixed together with the reversal potential and the slope on the sigmoid 194 
convolution of in-activation for the H-current (details of which parameters had a permitted variance 195 
is given in Table 1). This, coupled with the cell capacitances, differentiates the intrinsic activation of 196 
the ‘tp’ population from the ‘dp’ population. The populations also differed in their extrinsic 197 
connectivities, with ‘dp’ populations forming cortico-cortical connections and ‘tp’ populations 198 
allowing for cortico-thalamocortical connections. The thalamus was modelled implicitly, by an 80 ms 199 
delay in connectivity with permitted variance.  200 
Extrinsic connectivity between the six nodes is shown in Fig. 1b, with the detailed extrinsic 201 
population connections shown in Fig. 1c. In keeping with the established principle of differential 202 
cortical laminar projections of feed-forwards vs feedback connectivity (Bastos et al., 2012), backward 203 
connections are facilitated by the ‘dp’ cells terminating on ‘sp’ and ‘si’ cells, whilst forward 204 
connections run from ‘sp’ cells to ‘ss’ cells. Cortico-thalamo-cortical connections originate from ‘tp’ 205 
cells and terminate following a thalamic delay at layer 4 ‘ss’ cells. The presence or absence of 206 
connections between nodes was based on the fully connected models from Phillips et al., (2015) and 207 
Shaw et al., (2019), which in turn were derived from Garrido et al., (2008). This was used for the 208 
basis of an iterative process to find the most likely reduced model (described below). 209 
A Gaussian kernel (peak 60 ms, half-width 8 ms) represented auditory input to layer 4 stellates in 210 
bilateral auditory and inferior frontal cortex. 211 
Bayesian Modelling and Statistical Analysis:  212 
We used Bayesian model inversion (estimation) and Bayesian model comparison (selection) to 213 
identify the best explanation for subject-specific data, in terms of neuronal and biophysical 214 
parameters. Parametric Empirical Bayes (PEB) was used for group inferences and to examine drug 215 
effects, as described in Zeidman et al., (2019).  By inverting a ‘full’ DCM per subject at the first level, 216 
PEB avoids the problem of different first level DCMs falling into different local optima, and allows 217 
subsequent comparison between conditions. At the second level, the parameters of interest were 218 
included in the PEB, namely the GABAA synaptic connections. This restricted set of second level 219 
parameters was oriented to our GABA-ergic hypothesis, and to improve stability of neural system 220 
identifiability. 221 
The DCM was run for each subject. Data were filtered between 0–48 Hz and a Tukey window was 222 
applied that did not attenuate signals 50 ms before or 350 ms after stimuli. Inversion of the full 223 
model was run separately for the standard and deviant trials and the parameter distributions passed 224 
to second level Parametric Empirical Bayesian with contrasts for both trial types and drug conditions. 225 
All intrinsic and extrinsic AMPA, NMDA and GABA-A conductance scalings could vary independently 226 
in a manner that assumed symmetry between the two hemispheres. The prior means and permitted 227 
variances are summarised in Table 1.  228 
Variational Bayesian statistics using the Laplace approximation determined the probable parameter 229 
space given the neuronal model and the data (Friston et al., 2007). The full model parameter space 230 
was reduced by iteratively searching for dependencies in this parameter space and systematically 231 
removing parameters not contributing to the free energy of the system (Henson et al., 2011). The 232 
optimised reduced model comprises all those parameters and connections found to contribute 233 
significantly to the system temporal dynamics. The comparison of full and reduced models is 234 
conceptually analogous to F-tests in classical statistics, but inferences are Bayesian. A second-level 235 
PEB was run, optimizing GABAA-ergic synaptic parameters (representing inhibitory gain). This second 236 
level PEB identifies parameter that are estimated to differ significantly between task conditions, or 237 
differ between drug-sessions, or for which there is a drug-by-condition interaction. The parameter 238 
distributions from this reduced model were used to create a Bayesian model average of parameters 239 
that differ significantly across the contrasts of trial types and drug conditions. The implementation of 240 
PEB for model optimisation and contrast estimation is summarised in Fig. 1e.  241 
For other data types, Bayesian t-tests reported in the main text used JASP (JASP Team 2019, version 242 
0.10.2). Frequentist statistical methods reported in the main text used MATLAB (2017a, Mathworks, 243 
Natick, MA).  244 
Code Accessibility: The custom neuronal model used to generate these results is available 245 
at https://gitlab.com/tallie/edcm and works in conjunction with SPM12. 246 
  247 
Results 248 
Event related fields and induced spectral power 249 
Event related responses to standard and deviant trials were in line with previous findings (Hughes 250 
and Rowe, 2013; Phillips et al., 2015, 2016) (Fig. 2a, first and second rows) and show the expected 251 
M100, the primary response after the onset of a tone (80-120 ms), a difference signal (MMN) 252 
between the standard and deviant trials (150-250 ms) and an M300 visible in frontal nodes (250-380 253 
ms). The M100 was significantly reduced by tiagabine on standard and deviant trials, in left temporal 254 
nodes (A1, and STG p<0.05, paired t-test), whereas the later response leading into the M300 was 255 
significantly reduced only on deviant trials in L/R IFG (p<0.05, Bonferroni corrected for 6 regions). 256 
The difference waveform (i.e. the deviant – the standard) reveals a typical biphasic MMN between 257 
150-250ms, observed in primary auditory cortex and STG (Fig. 2a, third row). Tiagabine significantly 258 
reduced the second peak of the MMN (p<0.05) with bilateral IFG nodes and RSTG showing 259 
reductions in the first peak of the mismatch response on tiagabine (p<0.05). As with the deviant 260 
response, LIFG showed a significant reduction of the later MMN peak and the M300 on tiagabine 261 
(p<0.05).  262 
The temporal profile of spectral power differences (see Methods for time-frequency analysis) 263 
matched that of the ERFs, including spectral counterparts to M100, MMN, continuing through the 264 
M300 window (Fig. 2b&c). During the M100, alpha-power (8-12 Hz) decreases on tiagabine were 265 
localized to temporal cortex and beta (14-29 Hz) decreases more prominently to posterior temporal 266 
cortex. During the MMN, increases in low and high gamma (30-48 Hz and 52-80 Hz respectively) 267 
were observed broadly across right frontal cortex, including IFG. Low gamma also showed increases 268 
in right temporal cortex.  269 
Such changes in the observed spatiotemporal physiology on tiagabine will be dependent on changes 270 
in local and global network connectivity. The extended conductance-based dynamic causal model 271 
was therefore used to infer the causes of the observed physiological changes.   272 
The Dynamical Causal Model:  273 
The residuals (difference between the actual and generated ERFs) were greater (worse) for the 4-cell 274 
DCM than for the ext-DCM (Bayesian paired sample t-test: BF=8.5x1028) as shown in Fig. 3a. Bayesian 275 
model comparison of the 4-cell versus ext-DCM confirmed that the ext-DCM performed better (ie. 276 
was a more likely generator of the observed MEG) than the 4-cell DCM (BF = 40.6, Figure 3b). Note 277 
that the model-evidences are corrected for differences in model complexity. Further analyses use 278 
the ext-DCM only.  279 
Fig. 3c demonstrates the evoked-response generated by the conductance-based dynamic causal 280 
model at each node, for both drug conditions, using the optimal ext-DCM model as determined by 281 
Parametric Empirical Bayes (see methods). Fig. 3d shows the correlation between generated and 282 
observed data, for both standards’ and deviants’ responses, for both drug conditions at each node. 283 
Boxplots indicate the spread of single-subject correlations across the group (open circles are 284 
outliers), and black closed circles indicate the correlation of the mean response across all subjects 285 
for each condition and node. Note how the periods of difference between the placebo and drug 286 
conditions (black lines in Fig. 3c) are accurately generated (cf. ‘predicted’) by the model, with a high 287 
match to the observed data in Fig. 2a.  288 
The modelled responses are explained in terms of the parameters of the optimised model. Using 289 
parametric empirical Bayes, condition effects on model parameters (connection and synaptic 290 
parameters) were compared across the standard and deviant conditions, as well as across the 291 
placebo and tiagabine conditions. Figure 4 shows the effect of tiagabine on the intrinsic GABAergic 292 
connectivity, assuming symmetry (three bilateral averaged nodes are shown). We confirmed that 293 
tiagabine significantly increases tonic GABAergic inhibition (posterior probability given for each 294 
parameter in Fig. 4a). This was seen primarily in the deep layer pyramidal and interneuron 295 
populations in primary auditory cortex and STG (Fig. 4a).  An interaction between drug and condition 296 
was found for the deep interneurons of Auditory cortex (posterior p≈1.0).  297 
Fig. 4b compares GABA-A conductance scaling on deep interneurons between placebo and tiagabine 298 
conditions, plotted for each individual. There was very strong evidence for differences between the 299 
two drug conditions in primary auditory areas for the standard condition (BF=782356), and in IFG 300 
and STG for the deviant condition (BF=3.58x107 & BF=166 respectively). This difference between 301 
primary auditory cortex and association cortex in STG/IFG, is in keeping with the functional 302 
differentiation of upper versus lower levels in a hierarchical neural network with backwards 303 
prediction and forward prediction error. Conversely, there was evidence of no difference between 304 
the two drug conditions for the standard condition in IFG (BF=0.274) and for the deviant condition in 305 
Aud (BF=0.241).  306 
The correlation between tonic and phasic inhibition was explored for each region and condition. In 307 
the frontal cortex, a strong negative relationship was found between the tonic inhibition of deep 308 
inhibitory cells and their phasic inhibition onto cortico-thalamic cells (Fig. 4c Bayesian correlation 309 
pairs, BF=398.43). 310 
  311 
Discussion  312 
The principal insights from this study are that an extended conductance-based canonical mean-field 313 
method of dynamic causal modelling (a) succeeds in identifying the modulation of GABAergic 314 
dynamics by the GABA-reuptake inhibitor tiagabine, and (b) is tractable and an accurate generator of 315 
event-related fields that match those observed by magnetoencephalography, improving on an 316 
earlier 4-cell model. Moreover, the ext-DCM suggests the effect of drug to be both laminar-specific 317 
and dynamically modulated in different regions according to task condition. This opens the way for 318 
psychopharmacological studies in health and disease with the mechanistic precision afforded by 319 
using ext-DCMs as generative models.  320 
We demonstrate that the intrinsic connectivity within hierarchical brain networks changes between 321 
conditions in the mismatch task. The approach is of generalised relevance to hierarchical network 322 
models of cognition such as speech (Cope et al., 2018), semantic (Adams et al., 2019) and visual 323 
perception (Muthukumaraswamy et al., 2013). Moreover, the laminar and pharmacological 324 
specificity provided by the ext-DCM has the potential to quantify neuropathology in dementia, 325 
developmental and psychiatric disorders (Duyckaerts et al., 1986; Kinoshita et al., 1996; Ferrer, 326 
1999; Ji et al., 2018; Shaw et al., 2018). 327 
Understanding the MMN in terms of short-term plasticity.  328 
Tiagabine modulated the GABA-egic dynamics across the trial types, implicating both local tonic- and 329 
phasic effects. Repetitive activation with the same stimulus attenuated the ERF (reduction in N1/N2 330 
by 6th repetition, Fig. 2). The model indicated higher tonic inhibition in the deep layers. We interpret 331 
this as local short-term plastic changes in deep-layer inhibition (Knott et al., 2002; Hensch, 2005; 332 
Jääskeläinen et al., 2007), regulating salient information (Mongillo et al., 2018). 333 
The model suggested that tiagabine-induced increases of extracellular GABA leads to greater tonic 334 
inhibition, consistent with overspill of GABA onto extra-synaptic receptors (Semyanov et al., 2004). 335 
The effect was modulated differently in primary and associative processing areas: for tonic inhibition 336 
of deep interneurons the drug’s efficacy was highest in prefrontal cortex for deviant trials and in 337 
auditory cortex for standard trials. In other words, GABAergic effects are modulated differentially in 338 
upper and lower areas of the hierarchy dependent on the coding context. We speculate that this 339 
reflects differential emphasis on beliefs (& feedback predictions) versus feedforward sensory 340 
prediction errors in prefrontal versus primary auditory cortex; and that lower tonic inhibition at the 341 
presentation of a deviant tone relates to homeostatic competition between phasic and tonic 342 
inhibition (Wu et al., 2013). Increased phasic activation of deep-layer projections is necessary for 343 
feedback of top-down information on context, which in turn increases phasic (and decreased tonic) 344 
activation of deep interneurons. Decreasing tonic inhibition likely increases the interneuron 345 
population activation (Semyanov et al., 2004), leading to increased phasic inhibition onto deep 346 
pyramidal cells. This relationship was confirmed (Fig. 4c) between tonic inhibition of deep IFG 347 
interneurons and phasic inhibition of deep IFG thalamic-projection neurons. Figure 4b shows that 348 
whereas a drop in deep interneuron tonic inhibition was observed on deviant trials (vs standard), 349 
tiagabine abolished the effect. It is to be expected that increases in exogenous GABA would increase 350 
tonic GABAergic currents.  351 
GABA-ergic modulation of evoked and induced responses.  352 
Tiagabine affects oscillatory dynamics, which may influence behaviour (Coenen et al., 1995; 353 
Magazzini et al., 2016; Port et al., 2017; Wyss et al., 2017). It remains a challenge to relate systemic 354 
drug effects with local frequency-spectral phenomena. It has been proposed that beta-band activity 355 
is associated with infragranular cortical projection neurons with intrinsically bursting profiles (Groh 356 
et al., 2010; Roopun et al., 2010; Kim et al., 2015). We found that Tiagabine reduced the induced 357 
beta-band activity in temporal areas. The model suggests that tonic inhibition is increased on 358 
intrinsically bursting thalamic projection neurons in STG, which could increase rebound bursting via 359 
intrinsic M- and H-currents (Roopun et al., 2008; Roopun et al., 2008b). 360 
Conversely, it has been shown that gamma-band activity is dependent on the GABA-A receptor 361 
activation and the phasic interplay of interneuron-pyramidal cell networks, particularly in the 362 
superficial layers (Buffalo et al., 2011; Whittington et al., 2011). In the mismatch temporal window 363 
(Fig. 2b) peak gamma increased occurring at the start of the mismatch period. This is consistent with 364 
thalamic input (Di and Barth, 1992, 1993; Sukov and Barth, 2001) governing the envelope of gamma 365 
activity in the superficial layers (Metherate and Cruikshank, 1999). 366 
Overall, the observed dynamics and the model posterior parameters are consistent with knowledge 367 
of network activation within the context of beta- and gamma- rhythm generation in cortex. 368 
Generative models of drug effects on cognitive physiology. 369 
Tiagabine’s effect was largely confined to deep layers. As we modelled evoked activity it is difficult to 370 
speculate on how this influences gamma activity across the network, however a reduction in deep-371 
layer influence may increase local cortical processing associated with gamma-band activity in the 372 
superficial layers. As GABA levels are typically lower in older versus younger adults, tiagabine may 373 
act ‘restoratively’. This is corroborated with lower frequency responses that are dependent on GABA 374 
(Mathias et al., 2001). Finally, we speculate that the reduced M100 on tiagabine results from the 375 
widespread increased tonic inhibition represented in the model (Fig. 4), reducing local population 376 
activity. 377 
Study limitations. 378 
Our study was motivated by the need for mechanistic studies of human cortical function, underlying 379 
cognition, disease and therapeutics. Despite support for our three principal hypotheses, and 380 
background validation studies (Moran et al., 2014), evidence from one study may not generalise to 381 
other tasks and populations. There are study-specific considerations that limit our inferences, in 382 
relation to our participants, our model, and drug of choice. For example, our participants were 383 
healthy, and therefore have normal age related variance in GABA (Gao et al., 2013; Eavri et al., 384 
2018). They were older than those studied by Nutt et al (2015), and age-effects could interact with 385 
the effects of tiagabine (Nutt et al., 2015). Our study was not designed to examine the effect of age 386 
or ageing, but to focus on the normal brain in mid- and later-life. Further work would be required to 387 
examine the effects of ageing on the ext-DCM.  388 
Our model provides a simplified substrate for the neurophysiological processes. It is more detailed 389 
than previous canonical microcircuit convolution models (Moran et al., 2013), in an effort to improve 390 
the modelling of specific dynamics from distinct cell populations, their differing connectivities, 391 
synaptic time constants and voltage-gated conductances. The extended model can produce a 392 
spectrum of fast and slow responses, with fast responses involved in local processing dominated by 393 
superficial layers and slower responses associated with feedback of information dominated by deep 394 
layers (Roopun et al., 2006; Kramer et al., 2008; Whittington et al., 2011). It can incorporate delayed 395 
activity associated with local, cortico-cortical and cortico-thalamo-cortical connections. Currently, 396 
this system is a simplified network acting as a neural mass, and can represent relevant cortical 397 
interactions involved in ERF generation in the context of this task and study. It does this by allowing 398 
forward and backward modulation of activity between deep and superficial layers, where synaptic 399 
time constants corroborate with standard GABA, NMDA and AMPA receptor decays. The six 400 
specified nodes are commonly cited in the literature in the context of this task (Garrido et al., 2009b; 401 
Phillips et al., 2015). Although they are not a complete representation of possible network 402 
configurations, they have been shown to capture critical aspects of cortical function: here the 403 
network has been supplemented with modelled exogenous and endogenous inputs via thalamus.  404 
We emphasise Bayesian statistical analyses over classical frequentist methods. Where parameter 405 
estimates derived from earlier DCMs are used for frequentist statistical tests, they have excellent 406 
reliability across sessions, and similar power to fMRI and EEG studies (Rowe et al., 2010; Goulden et 407 
al., 2012; Bernal-Casas et al., 2013). Frequentist approaches are familiar to many readers, and have 408 
been the norm for comparison of ERFs, and we therefore include them selectively. Such a 409 
frequentist approach is surpassed by the direct inferences on posterior probability inherent in DCMs 410 
Bayesian inference, including PEB.  411 
Tiagabine is a relatively specific blocker of GAT-1 at the concentrations used, but does not 412 
distinguish between the mechanisms activated by GABA (Bowery et al., 1987; Mody and Pearce, 413 
2004; Lee and Maguire, 2014). The timing of the magnetoencephalography coincided with expected 414 
peak plasma levels, but levels may vary between individuals and future studies could include levels 415 
as a covariate of interest, or model time-varying responses in relation to drug levels 416 
(Muthukumaraswamy et al., 2013b). 417 
In conclusion, we have used a conductance-based model of cortical neuronal dynamics to study 418 
GABA-ergic interactions and probe laminar-specific physiological responses to tiagabine. The model 419 
accurately generated physiological data that matched the MEG responses and confirmed the effect 420 
of tiagabine on tonic GABA-A inhibitory gain within frontal and temporal cortical circuits. Our data 421 
provide support for mechanistic studies of neurological disorders, including but not limited to 422 
GABAergic impairments (Murley and Rowe, 2018). They also point to new approaches for 423 
experimental medicine studies in humans that aim for the laminar, cellular or synaptic precision 424 
made possible in new generations of dynamic causal models. 425 
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 738 
  739 
Figure Legends 740 
Figure 1. The neuronal model. 741 
a. Intrinsic connectivities found in all nodes between layer 4 stellates (ss), inhibitory interneurons (ii), 742 
superficial pyramidal modules (sp) and deep pyramidal modules (dp). 743 
b. All 6 nodes used are represented as a network on the left, showing the extrinsic connectivities 744 
(solid line = forward; dotted line = backward; dashed line = lateral). A left hemisphere representation 745 
of these bilateral nodes in primary auditory cortex, superior temporal gyrus and inferior-frontal 746 
gyrus (light, medium and dark grey, respectively). 747 
c. A detailed view of the extrinsic population connections for forward (solid lines) and backward 748 
(dotted lines) connections. 749 
d. Matrices of the extrinsic and intrinsic connectivity weights, all of which had a permitted variance 750 
of 1/16. 751 
e. A process flow describing the steps taken in the meta-analysis phase. 752 
 753 
Figure 2. Event Related Fields (ERFs). 754 
a. Mean ERFs across all subjects for all six nodes for the standard and deviant trials from 0-380ms. 755 
The difference wave (MMN) is also shown. ERFs from the placebo condition are shown in blue and 756 
from the tiagabine condition in red. Significant changes with time across the drug condition are 757 
shown as a thick black line within each axis (p<0.05, Bonferroni corrected for 6 regions). Shaded 758 
areas represent the standard error (SEM). 759 
b. Significant differences for induced spectra power were found in the alpha (α), beta (β) and lower 760 
and higher gamma bands (γ1 and γ2) (FWE cluster corrected at p<0.001). Here they are shown as flat 761 
scalp maps (lower plots) with rostro-caudal activity versus time (upper plots). The time axis runs 762 
from 0–380 ms post-stimulus. 763 
c. Source-reconstructed T-contrasts (p<0.001) created for those frequency bands showing spatial 764 
changes across the drug condition in the 135 – 235 ms time window. 765 
 766 
Figure 3. Comparison between model and data. 767 
a. Residual differences between the observed and model-generated ERFs are shown for both the 768 
standard 4-cell conductance-based DCM and the ext-DCM. ERFs from all nodes for every subject are 769 
concatenated along the y-axis. 770 
b. Bayesian model comparison of the 4-cell conductance-based DCM and the ext-DCM favours the 771 
ext-DCM, plotted here in terms of the posterior model probability (RFX Bayes Factor = 40.6). 772 
c. Predicted ERFs are shown for the standard and deviant conditions, along with the difference wave 773 
(Std–Dev). The placebo and tiagabine conditions are depicted in blue and red respectively with 774 
significant differences (p<0.05, Bonferroni corrected for 6 regions) shown as a thick black line within 775 
each axis. 776 
d. Correlation coefficient between prediction and data for each node and each condition. Boxplots 777 
represent the distribution over subjects with small dots representing outliers and larger black circles 778 
representing the correlation coefficient of the meaned response of all subjects for each node and 779 
each condition. 780 
 781 
Figure 4. Prediction of hidden states. 782 
a. Significant differences in the modulation of GABA-A synaptic scaling for each of the three 783 
symmetric nodes. Green/red show significantly greater/lesser GABA-A synaptic scaling for tiagabine 784 
than the placebo. Posterior probability p-values are shown next to each connection. 785 
b. To explore the functional differentiation between regions during the task conditions with respect 786 
to tonic inhibition, tonic GABA-A scaling on deep interneurons in IFG, STG and Aud, for each 787 
individual is plotted for the placebo and tiagabine conditions. The standard and deviant conditions 788 
are plotted separately in the left and right columns respectively. Pair-wise Bayesian t-test statistics 789 
are reported on each plot, showing the Bayes Factor for each of the 6 comparisons. When there is 790 
evidence for a difference, or evidence for no difference, the Bayes factor is shown in green or blue 791 
respectively. 792 
c. The correlation demonstrates the dynamic balance that persists between phasic and tonic 793 
inhibition (see main text discussion). Linear fit with 95% confidence bounds for tonic GABA-A scaling 794 
on deep inhibitory neurons vs phasic GABA-A scaling from deep inhibitory neurons to thalamic 795 
projecting pyramidals (Bayesian correlation pairs, Bayes factor=398.43). 796 
 797 
 798 
Table 1. Model parameters. 799 
Parameter values used by the neuronal model are shown with their permitted variances. 800 
 801 
Parameter grouping Parameter Initial value Permitted variance
Decay
Constants, τ (ms)
AMPA τ 4 1/16
NMDA τ 100 1/16
GABAA τ 16 1/8
GABAB τ 200 1/8
IM τ 160 0
IH τ 100 0
Misc. strengths
K+ leak G 1 0
Background V 2.17 1/32
Reversal potentials (mV)
Na2+ reversal 60 0
Ca2+ reversal 10 0
Cl- reversal -90 0
K+ reversal -70 0
IH reversal -100 0
Firing threshold (mV) VT (all pops) -40 0
Firing precision VX (all pops) 1 1/32
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BF = 0.274 BF = 3.58x107
PO = 1.693 BF = 166.2
BF = 0.241BF = 782356
